Total amount raised
$748.1 Millions
Latest funding date
11/01/2024
Location
Humacyte has developed a pioneering platform for bioengineered human tissues and organs designed to be universally implantable, off-the-shelf, and regenerative. The company has successfully raised significant funding to advance its innovative products, including the FDA-approved Symvess™ for vascular trauma repair.
Keep reading to explore the intricacies of Humacyte's fundraising journey and the investors backing this groundbreaking platform.
What Is Humacyte?
Humacyte Global, Inc. is a pioneering company in the field of bioengineering and regenerative medicine. Based in Durham, NC, the company focuses on developing and manufacturing bioengineered human tissues and organs designed to be universally implantable, off-the-shelf, and regenerative.
With a mission to turn science fiction into science fact, Humacyte has received FDA approval for its product Symvess™ and is building an extensive portfolio of investigational product candidates to address various clinical needs. The company aims to treat a wide variety of diseases, injuries, and chronic conditions through its innovative platform.
How Much Funding Has Humacyte Raised?
- Round Name: Series B
- Amount Raised: $150M
- Date: Oct 20, 2015
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate the development of bioengineered human tissues and organs.
- Round Name: Venture Round
- Amount Raised: $10M
- Date: Aug 9, 2016
- Lead Investors: California Institute for Regenerative Medicine
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support ongoing research and development efforts.
- Round Name: Grant
- Amount Raised: $14.1M
- Date: Sep 29, 2017
- Lead Investors: California Institute for Regenerative Medicine
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund specific research projects in regenerative medicine.
- Round Name: Series C
- Amount Raised: $75M
- Date: Mar 12, 2018
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand clinical trials and advance product development.
- Round Name: Corporate Round
- Amount Raised: $150M
- Date: Jun 11, 2018
- Lead Investors: Fresenius Medical Care
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To form strategic partnerships and enhance product offerings.
- Round Name: Debt Financing
- Amount Raised: $49.8M
- Date: Jan 16, 2015
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To secure working capital for ongoing operations.
- Round Name: Debt Financing
- Amount Raised: $50M
- Date: Apr 14, 2021
- Lead Investors: Silicon Valley Bank
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the company's growth and expansion plans.
- Round Name: Post-IPO Equity
- Amount Raised: $175M
- Date: Aug 27, 2021
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance market presence and scale operations.
- Round Name: Post-IPO Equity
- Amount Raised: $40.2M
- Date: Feb 29, 2024
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund new product development and market expansion.
- Round Name: Post-IPO Equity
- Amount Raised: $15M
- Date: Nov 14, 2024
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To strengthen financial stability and support ongoing projects.
Humacyte has raised a total of $729.1M. The current valuation is Not publicly disclosed.
Key Investors
Based on the provided sources, here is an unordered list of the major investors in Humacyte:
- Silicon Valley Bank
- Details: Silicon Valley Bank is a high-tech commercial bank that primarily serves technology, life sciences, and venture capital clients. It is known for providing a range of financial services to startups and established companies.
- Investment Focus Areas: Technology, life sciences, venture capital.
- Notable Investments: Not publicly disclosed.
- Fresenius Medical Care
- Details: Fresenius Medical Care is a global healthcare company specializing in dialysis services and products. It operates a network of dialysis clinics and provides a range of healthcare services.
- Investment Focus Areas: Healthcare, medical devices, dialysis services.
- Notable Investments: Not publicly disclosed.
- California Institute for Regenerative Medicine
- Details: The California Institute for Regenerative Medicine (CIRM) is a state agency that funds stem cell research and regenerative medicine projects. It aims to accelerate the development of treatments and cures for various diseases.
- Investment Focus Areas: Stem cell research, regenerative medicine, biotechnology.
- Notable Investments: Not publicly disclosed.
What's Next for Humacyte?
Humacyte stands at the forefront of regenerative medicine, with opportunities to revolutionize the field through its bioengineered human tissues and organs. The company's focus on universally implantable, off-the-shelf products positions it to address significant clinical needs, potentially transforming patient care on a global scale.
Future fundraising efforts will likely be driven by the need to expand clinical trials and bring new products to market. As the industry trends towards advanced medical technologies, Humacyte's innovative platform could attract substantial investment, enabling further growth and development.
However, challenges such as maintaining clear communication and user experience on their digital platforms could pose obstacles. Ensuring robust website maintenance and accessible information will be crucial as Humacyte continues to scale its operations and reach new milestones in regenerative medicine.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Humacyte and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
